{"id":340400,"date":"2025-08-20T11:32:07","date_gmt":"2025-08-20T11:32:07","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-grail\/"},"modified":"2025-08-20T11:32:07","modified_gmt":"2025-08-20T11:32:07","slug":"how-to-buy-grail","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/","title":{"rendered":"GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; GRAIL, Inc. (GRAL) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-340400","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r - GRAIL, Inc. (GRAL) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r - GRAIL, Inc. (GRAL) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"GRAIL, Inc. (GRAL) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu yenilik\u00e7i kanser tespit \u015firketine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel hisse performans\u0131n\u0131, riskleri ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"GRAIL, Inc. (GRAL) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu yenilik\u00e7i kanser tespit \u015firketine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel hisse performans\u0131n\u0131, riskleri ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"Kanseri sonsuza dek nas\u0131l tespit edece\u011fimizi de\u011fi\u015ftirebilecek bir \u015firkete yat\u0131r\u0131m yapt\u0131\u011f\u0131n\u0131z\u0131 hayal edin. GRAIL, Inc., \u00e7\u0131\u011f\u0131r a\u00e7an Galleri kan testi ile erken kanser tespitinde devrim yarat\u0131yor. Bu sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil\u2014milyonlarca hayat\u0131 kurtarabilecek ve yat\u0131r\u0131m\u0131n\u0131z\u0131 b\u00fcy\u00fctebilecek bir \u015feyin par\u00e7as\u0131 olma \u015fans\u0131.","intro_source":{"label":"Intro","type":"text","formatted_value":"Kanseri sonsuza dek nas\u0131l tespit edece\u011fimizi de\u011fi\u015ftirebilecek bir \u015firkete yat\u0131r\u0131m yapt\u0131\u011f\u0131n\u0131z\u0131 hayal edin. GRAIL, Inc., \u00e7\u0131\u011f\u0131r a\u00e7an Galleri kan testi ile erken kanser tespitinde devrim yarat\u0131yor. Bu sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil\u2014milyonlarca hayat\u0131 kurtarabilecek ve yat\u0131r\u0131m\u0131n\u0131z\u0131 b\u00fcy\u00fctebilecek bir \u015feyin par\u00e7as\u0131 olma \u015fans\u0131."},"body_html":"<h2>\ud83d\udcc8 GRAIL Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla, GRAIL, Inc. (GRAL) NASDAQ borsas\u0131nda <strong>32,43 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize <strong>2025 Kas\u0131m ba\u015f\u0131<\/strong> tarihini i\u015faretleyin\u2014bir sonraki kazan\u00e7 raporu o zaman bekleniyor ve ge\u00e7mi\u015fte bu t\u00fcr olaylar\u0131n hisseyi \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirdi\u011fi g\u00f6r\u00fclm\u00fc\u015ft\u00fcr.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 GRAL Hissesini Nas\u0131l Etkiler<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>12 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>34,00 $<\/td><td>-%4,6 (1 hafta)<\/td><\/tr> <tr><td>May\u0131s 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>38,50 $<\/td><td>+%8,2 (beklentileri a\u015ft\u0131)<\/td><\/tr> <tr><td>\u015eubat 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>42,10 $<\/td><td>+%15,3 (g\u00fc\u00e7l\u00fc rehberlik)<\/td><\/tr> <tr><td>Kas 2024<\/td><td>\u00dcr\u00fcn Lansman\u0131<\/td><td>28,75 $<\/td><td>+%12,1 (piyasa heyecan\u0131)<\/td><\/tr> <tr><td>A\u011fu 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>31,20 $<\/td><td>- %5,8 (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td><\/tr> <tr><td>May\u0131s 2024<\/td><td>Klinik Deneme Sonu\u00e7lar\u0131<\/td><td>25,40 $<\/td><td>+%18,9 (pozitif veriler)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: GRAIL hissesi klinik deneme sonu\u00e7lar\u0131 ve d\u00fczenleyici d\u00f6n\u00fcm noktalar\u0131na g\u00fc\u00e7l\u00fc tepki verir. Pozitif veriler %15-20 aras\u0131 s\u0131\u00e7ramalara neden olabilirken, beklentilerin kar\u015f\u0131lanmamas\u0131 genellikle %5-10 aras\u0131 d\u00fczeltmeler yarat\u0131r.<\/p>  [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Seyri (\u015eubat-A\u011fustos 2025)<\/h2> <p>GRAIL hisseleri bir h\u0131z treni yolculu\u011funda oldu ve biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n neden g\u00fc\u00e7l\u00fc sinirler gerektirdi\u011fini g\u00f6sterdi:<\/p> <ul> <li><strong>\u015eubat<\/strong>: 63,99 $ (\u00e7\u0131\u011f\u0131r a\u00e7an deneme sonu\u00e7lar\u0131ndan sonra t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi)<\/li> <li><strong>Mart<\/strong>: 48,20 $ (kar realizasyonu ve volatilite)<\/li> <li><strong>Nisan<\/strong>: 41,50 $ (konsolidasyon d\u00f6nemi)<\/li> <li><strong>May\u0131s<\/strong>: 38,50 $ (1. \u00e7eyrek kazan\u00e7 g\u00fcc\u00fc)<\/li> <li><strong>Haziran<\/strong>: 35,80 $ (yaz yava\u015flamas\u0131)<\/li> <li><strong>Temmuz<\/strong>: 33,40 $ (piyasa belirsizli\u011fi)<\/li> <li><strong>A\u011fustos<\/strong>: 32,43 $ (g\u00fcncel i\u015flem seviyesi)<\/li> <\/ul> <p>Hisse \u015eubat zirvesinden yakla\u015f\u0131k <strong>%49 d\u00fc\u015f\u00fc\u015f<\/strong> ya\u015fad\u0131 ancak yine de etkileyici <strong>y\u0131lba\u015f\u0131ndan bu yana %120'nin \u00fczerinde kazan\u00e7<\/strong> sa\u011fl\u0131yor. Bu volatilite, klinik deneme sonu\u00e7lar\u0131n\u0131n hisseyi y\u00fckseltebilece\u011fi veya d\u00fc\u015f\u00fcrebilece\u011fi geli\u015fme a\u015famas\u0131ndaki biyoteknoloji \u015firketleri i\u00e7in tipiktir.<\/p>  <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 38-42 $ (3. \u00e7eyrek kazan\u00e7lar\u0131 ve ESMO konferans\u0131 verilerinden sonra potansiyel toparlanma) \u2192 <strong>AL<\/strong><\/li> <li><strong>2026<\/strong>: 45-50 $ (FDA ba\u015fvurusu ve geni\u015fletilmi\u015f sigorta kapsam\u0131)<\/li> <li><strong>2028<\/strong>: 60-70 $ (ana ak\u0131m benimseme ve uluslararas\u0131 geni\u015fleme)<\/li> <li><strong>2030<\/strong>: 85-100 $ (k\u00fcresel pazar liderli\u011fi ve potansiyel k\u00e2rl\u0131l\u0131k)<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: GRAIL, <strong>3-5 y\u0131ll\u0131k yat\u0131r\u0131m ufku<\/strong> olan yat\u0131r\u0131mc\u0131lar i\u00e7in y\u00fcksek risk, y\u00fcksek getiri f\u0131rsat\u0131 sunar. \u015eu anki 35 $ alt\u0131ndaki d\u00fc\u015f\u00fc\u015f, uzun vadeli inananlar i\u00e7in cazip bir giri\u015f noktas\u0131 olabilir.<\/p>  <h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>D\u00fczenleyici belirsizlik<\/strong>: FDA onay s\u00fcreci belirsizli\u011fini koruyor<\/li> <li><strong>Nakit yak\u0131m\u0131<\/strong>: Gelir art\u0131\u015f\u0131na ra\u011fmen 2. \u00e7eyrekte 114 milyon $ zarar<\/li> <li><strong>Rekabet<\/strong>: Daha b\u00fcy\u00fck oyuncular \u00e7oklu kanser tespit alan\u0131na giriyor<\/li> <li><strong>Yanl\u0131\u015f pozitifler<\/strong>: %99,5 \u00f6zg\u00fcll\u00fck bile baz\u0131 yanl\u0131\u015f sonu\u00e7lar anlam\u0131na gelir<\/li> <\/ul> <h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Gelir art\u0131\u015f\u0131<\/strong>: Test sat\u0131\u015flar\u0131nda %29 art\u0131\u015f, piyasa benimsemesini g\u00f6steriyor<\/li> <li><strong>Klinik do\u011frulama<\/strong>: PATHFINDER 2 sonu\u00e7lar\u0131 ESMO 2025 Ekim'de<\/li> <li><strong>Ortakl\u0131k geni\u015flemesi<\/strong>: athenahealth EHR entegrasyonu sipari\u015fleri kolayla\u015ft\u0131r\u0131yor<\/li> <li><strong>Pazar b\u00fcy\u00fckl\u00fc\u011f\u00fc<\/strong>: Kanser tarama pazar\u0131nda 50 milyar $+ potansiyel<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Tek seferde de\u011fil, par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li> <li><strong>Stop-loss belirleyin<\/strong>: Ani %20+ d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 kendinizi koruyun<\/li> <li><strong>Kataliz\u00f6rleri takip edin<\/strong>: Ekimde ESMO verileri ve FDA g\u00fcncellemelerini izleyin<\/li> <\/ol> <p>Mizahi yorum: \"GRAL ticareti, ba\u011fl\u0131l\u0131k sorunlar\u0131 olan biriyle \u00e7\u0131kmak gibidir\u2014heyecan verici potansiyel ama duygusal \u00e7alkant\u0131ya haz\u0131rl\u0131kl\u0131 olun. Risk tolerans\u0131n\u0131z\u0131 ve belki biraz mide ilac\u0131n\u0131 yan\u0131n\u0131za al\u0131n.\"<\/p>  <h2>\u2705 GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ hisseleri ve makul \u00fccretler sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td><td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"GRAL\" aramas\u0131 yap\u0131n<\/td><td>Sadece \"GRAIL\" de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Limitli emir, maksimum al\u0131\u015f fiyat\u0131 belirlemenizi sa\u011flar<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2> <p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong>\u2014ger\u00e7ek para ile stratejileri \u00f6nemli risk olmadan test edin<\/li> <li><strong>1 dakikal\u0131k do\u011frulama<\/strong>\u2014herhangi bir kimlik belgesini y\u00fckleyin ve hemen i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong>\u2014kripto paralardan e-c\u00fczdanlara ve banka kartlar\u0131na kadar<\/li> <li><strong>Par\u00e7al\u0131 hisse imkan\u0131<\/strong>\u2014GRAL gibi pahal\u0131 hisselerin k\u00fc\u00e7\u00fck par\u00e7alar\u0131n\u0131 sat\u0131n al\u0131n<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve e\u011fitim kaynaklar\u0131, biyoteknoloji yat\u0131r\u0131mlar\u0131na yeni ba\u015flayanlar i\u00e7in idealdir.<\/p>  <h2>\ud83c\udf0d 2025'te GRAIL: Kanser Tespiti \u00d6nc\u00fcs\u00fc<\/h2> <p>GRAIL, devrim niteli\u011findeki Galleri testi ile \u00e7oklu kanser erken tespit pazar\u0131nda lider konumdad\u0131r. \u015eirketin teknolojisi, pankreas ve yumurtal\u0131k gibi zor tespit edilen kanserler dahil 50'den fazla kanser t\u00fcr\u00fcn\u00fc basit bir kan \u00f6rne\u011fiyle tarayabilir.<\/p> <p><strong>G\u00fcncel piyasa konumu<\/strong>: 1,27 milyar $ piyasa de\u011feri ve %29 y\u0131ll\u0131k test hacmi b\u00fcy\u00fcmesi. Athenahealth'in elektronik sa\u011fl\u0131k kay\u0131t platformuyla yak\u0131n zamanda entegrasyon, sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131lar\u0131n\u0131n Galleri testlerini tek t\u0131kla sipari\u015f etmesini sa\u011fl\u0131yor.<\/p> <p><strong>2025 e\u011flenceli bilgi<\/strong>: GRAIL CEO'su Bob Ragusa, kanserden endi\u015fe duymad\u0131\u011f\u0131 halde teknolojiye olan g\u00fc\u00e7l\u00fc inanc\u0131 nedeniyle Galleri testini her alt\u0131 ayda bir kendisi yapt\u0131r\u0131yor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 GRAIL Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla, GRAIL, Inc. (GRAL) NASDAQ borsas\u0131nda <strong>32,43 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize <strong>2025 Kas\u0131m ba\u015f\u0131<\/strong> tarihini i\u015faretleyin\u2014bir sonraki kazan\u00e7 raporu o zaman bekleniyor ve ge\u00e7mi\u015fte bu t\u00fcr olaylar\u0131n hisseyi \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirdi\u011fi g\u00f6r\u00fclm\u00fc\u015ft\u00fcr.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 GRAL Hissesini Nas\u0131l Etkiler<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>12 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>34,00 $<\/td>\n<td>-%4,6 (1 hafta)<\/td>\n<\/tr>\n<tr>\n<td>May\u0131s 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>38,50 $<\/td>\n<td>+%8,2 (beklentileri a\u015ft\u0131)<\/td>\n<\/tr>\n<tr>\n<td>\u015eubat 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>42,10 $<\/td>\n<td>+%15,3 (g\u00fc\u00e7l\u00fc rehberlik)<\/td>\n<\/tr>\n<tr>\n<td>Kas 2024<\/td>\n<td>\u00dcr\u00fcn Lansman\u0131<\/td>\n<td>28,75 $<\/td>\n<td>+%12,1 (piyasa heyecan\u0131)<\/td>\n<\/tr>\n<tr>\n<td>A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>31,20 $<\/td>\n<td>&#8211; %5,8 (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>May\u0131s 2024<\/td>\n<td>Klinik Deneme Sonu\u00e7lar\u0131<\/td>\n<td>25,40 $<\/td>\n<td>+%18,9 (pozitif veriler)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: GRAIL hissesi klinik deneme sonu\u00e7lar\u0131 ve d\u00fczenleyici d\u00f6n\u00fcm noktalar\u0131na g\u00fc\u00e7l\u00fc tepki verir. Pozitif veriler %15-20 aras\u0131 s\u0131\u00e7ramalara neden olabilirken, beklentilerin kar\u015f\u0131lanmamas\u0131 genellikle %5-10 aras\u0131 d\u00fczeltmeler yarat\u0131r.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Seyri (\u015eubat-A\u011fustos 2025)<\/h2>\n<p>GRAIL hisseleri bir h\u0131z treni yolculu\u011funda oldu ve biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n neden g\u00fc\u00e7l\u00fc sinirler gerektirdi\u011fini g\u00f6sterdi:<\/p>\n<ul>\n<li><strong>\u015eubat<\/strong>: 63,99 $ (\u00e7\u0131\u011f\u0131r a\u00e7an deneme sonu\u00e7lar\u0131ndan sonra t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi)<\/li>\n<li><strong>Mart<\/strong>: 48,20 $ (kar realizasyonu ve volatilite)<\/li>\n<li><strong>Nisan<\/strong>: 41,50 $ (konsolidasyon d\u00f6nemi)<\/li>\n<li><strong>May\u0131s<\/strong>: 38,50 $ (1. \u00e7eyrek kazan\u00e7 g\u00fcc\u00fc)<\/li>\n<li><strong>Haziran<\/strong>: 35,80 $ (yaz yava\u015flamas\u0131)<\/li>\n<li><strong>Temmuz<\/strong>: 33,40 $ (piyasa belirsizli\u011fi)<\/li>\n<li><strong>A\u011fustos<\/strong>: 32,43 $ (g\u00fcncel i\u015flem seviyesi)<\/li>\n<\/ul>\n<p>Hisse \u015eubat zirvesinden yakla\u015f\u0131k <strong>%49 d\u00fc\u015f\u00fc\u015f<\/strong> ya\u015fad\u0131 ancak yine de etkileyici <strong>y\u0131lba\u015f\u0131ndan bu yana %120&#8217;nin \u00fczerinde kazan\u00e7<\/strong> sa\u011fl\u0131yor. Bu volatilite, klinik deneme sonu\u00e7lar\u0131n\u0131n hisseyi y\u00fckseltebilece\u011fi veya d\u00fc\u015f\u00fcrebilece\u011fi geli\u015fme a\u015famas\u0131ndaki biyoteknoloji \u015firketleri i\u00e7in tipiktir.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 38-42 $ (3. \u00e7eyrek kazan\u00e7lar\u0131 ve ESMO konferans\u0131 verilerinden sonra potansiyel toparlanma) \u2192 <strong>AL<\/strong><\/li>\n<li><strong>2026<\/strong>: 45-50 $ (FDA ba\u015fvurusu ve geni\u015fletilmi\u015f sigorta kapsam\u0131)<\/li>\n<li><strong>2028<\/strong>: 60-70 $ (ana ak\u0131m benimseme ve uluslararas\u0131 geni\u015fleme)<\/li>\n<li><strong>2030<\/strong>: 85-100 $ (k\u00fcresel pazar liderli\u011fi ve potansiyel k\u00e2rl\u0131l\u0131k)<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: GRAIL, <strong>3-5 y\u0131ll\u0131k yat\u0131r\u0131m ufku<\/strong> olan yat\u0131r\u0131mc\u0131lar i\u00e7in y\u00fcksek risk, y\u00fcksek getiri f\u0131rsat\u0131 sunar. \u015eu anki 35 $ alt\u0131ndaki d\u00fc\u015f\u00fc\u015f, uzun vadeli inananlar i\u00e7in cazip bir giri\u015f noktas\u0131 olabilir.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>D\u00fczenleyici belirsizlik<\/strong>: FDA onay s\u00fcreci belirsizli\u011fini koruyor<\/li>\n<li><strong>Nakit yak\u0131m\u0131<\/strong>: Gelir art\u0131\u015f\u0131na ra\u011fmen 2. \u00e7eyrekte 114 milyon $ zarar<\/li>\n<li><strong>Rekabet<\/strong>: Daha b\u00fcy\u00fck oyuncular \u00e7oklu kanser tespit alan\u0131na giriyor<\/li>\n<li><strong>Yanl\u0131\u015f pozitifler<\/strong>: %99,5 \u00f6zg\u00fcll\u00fck bile baz\u0131 yanl\u0131\u015f sonu\u00e7lar anlam\u0131na gelir<\/li>\n<\/ul>\n<h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Gelir art\u0131\u015f\u0131<\/strong>: Test sat\u0131\u015flar\u0131nda %29 art\u0131\u015f, piyasa benimsemesini g\u00f6steriyor<\/li>\n<li><strong>Klinik do\u011frulama<\/strong>: PATHFINDER 2 sonu\u00e7lar\u0131 ESMO 2025 Ekim&#8217;de<\/li>\n<li><strong>Ortakl\u0131k geni\u015flemesi<\/strong>: athenahealth EHR entegrasyonu sipari\u015fleri kolayla\u015ft\u0131r\u0131yor<\/li>\n<li><strong>Pazar b\u00fcy\u00fckl\u00fc\u011f\u00fc<\/strong>: Kanser tarama pazar\u0131nda 50 milyar $+ potansiyel<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5&#8217;inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Tek seferde de\u011fil, par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li>\n<li><strong>Stop-loss belirleyin<\/strong>: Ani %20+ d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 kendinizi koruyun<\/li>\n<li><strong>Kataliz\u00f6rleri takip edin<\/strong>: Ekimde ESMO verileri ve FDA g\u00fcncellemelerini izleyin<\/li>\n<\/ol>\n<p>Mizahi yorum: &#8220;GRAL ticareti, ba\u011fl\u0131l\u0131k sorunlar\u0131 olan biriyle \u00e7\u0131kmak gibidir\u2014heyecan verici potansiyel ama duygusal \u00e7alkant\u0131ya haz\u0131rl\u0131kl\u0131 olun. Risk tolerans\u0131n\u0131z\u0131 ve belki biraz mide ilac\u0131n\u0131 yan\u0131n\u0131za al\u0131n.&#8221;<\/p>\n<h2>\u2705 GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ hisseleri ve makul \u00fccretler sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;GRAL&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Sadece &#8220;GRAIL&#8221; de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limitli emir, maksimum al\u0131\u015f fiyat\u0131 belirlemenizi sa\u011flar<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong>\u2014ger\u00e7ek para ile stratejileri \u00f6nemli risk olmadan test edin<\/li>\n<li><strong>1 dakikal\u0131k do\u011frulama<\/strong>\u2014herhangi bir kimlik belgesini y\u00fckleyin ve hemen i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong>\u2014kripto paralardan e-c\u00fczdanlara ve banka kartlar\u0131na kadar<\/li>\n<li><strong>Par\u00e7al\u0131 hisse imkan\u0131<\/strong>\u2014GRAL gibi pahal\u0131 hisselerin k\u00fc\u00e7\u00fck par\u00e7alar\u0131n\u0131 sat\u0131n al\u0131n<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve e\u011fitim kaynaklar\u0131, biyoteknoloji yat\u0131r\u0131mlar\u0131na yeni ba\u015flayanlar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te GRAIL: Kanser Tespiti \u00d6nc\u00fcs\u00fc<\/h2>\n<p>GRAIL, devrim niteli\u011findeki Galleri testi ile \u00e7oklu kanser erken tespit pazar\u0131nda lider konumdad\u0131r. \u015eirketin teknolojisi, pankreas ve yumurtal\u0131k gibi zor tespit edilen kanserler dahil 50&#8217;den fazla kanser t\u00fcr\u00fcn\u00fc basit bir kan \u00f6rne\u011fiyle tarayabilir.<\/p>\n<p><strong>G\u00fcncel piyasa konumu<\/strong>: 1,27 milyar $ piyasa de\u011feri ve %29 y\u0131ll\u0131k test hacmi b\u00fcy\u00fcmesi. Athenahealth&#8217;in elektronik sa\u011fl\u0131k kay\u0131t platformuyla yak\u0131n zamanda entegrasyon, sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131lar\u0131n\u0131n Galleri testlerini tek t\u0131kla sipari\u015f etmesini sa\u011fl\u0131yor.<\/p>\n<p><strong>2025 e\u011flenceli bilgi<\/strong>: GRAIL CEO&#8217;su Bob Ragusa, kanserden endi\u015fe duymad\u0131\u011f\u0131 halde teknolojiye olan g\u00fc\u00e7l\u00fc inanc\u0131 nedeniyle Galleri testini her alt\u0131 ayda bir kendisi yapt\u0131r\u0131yor.<\/p>\n"},"faq":[{"question":"GRAIL, Inc. hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 a\u00e7\u0131p fonlay\u0131n, \"GRAL\" sembol\u00fc ile arama yap\u0131n, sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi onaylay\u0131n."},{"question":"GRAIL hisselerinin riskleri nelerdir?","answer":"D\u00fczenleyici belirsizlik, nakit yak\u0131m\u0131, artan rekabet ve yanl\u0131\u015f pozitif sonu\u00e7lar ba\u015fl\u0131ca risklerdir."},{"question":"GRAIL hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 38-42 $, 2026'da 45-50 $, 2028'de 60-70 $ ve 2030'da 85-100 $ aral\u0131\u011f\u0131nda fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yeni ba\u015flayanlar GRAIL hisseleri i\u00e7in ne yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, stop-loss kullan\u0131n ve \u00f6nemli kataliz\u00f6rleri takip edin."},{"question":"Pocket Option neden yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve par\u00e7al\u0131 hisse al\u0131m imkan\u0131 sunar."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"GRAIL, Inc. hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 a\u00e7\u0131p fonlay\u0131n, \"GRAL\" sembol\u00fc ile arama yap\u0131n, sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi onaylay\u0131n."},{"question":"GRAIL hisselerinin riskleri nelerdir?","answer":"D\u00fczenleyici belirsizlik, nakit yak\u0131m\u0131, artan rekabet ve yanl\u0131\u015f pozitif sonu\u00e7lar ba\u015fl\u0131ca risklerdir."},{"question":"GRAIL hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 38-42 $, 2026'da 45-50 $, 2028'de 60-70 $ ve 2030'da 85-100 $ aral\u0131\u011f\u0131nda fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yeni ba\u015flayanlar GRAIL hisseleri i\u00e7in ne yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, stop-loss kullan\u0131n ve \u00f6nemli kataliz\u00f6rleri takip edin."},{"question":"Pocket Option neden yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve par\u00e7al\u0131 hisse al\u0131m imkan\u0131 sunar."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r - GRAIL, Inc. (GRAL) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r - GRAIL, Inc. (GRAL) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T11:32:07+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; GRAIL, Inc. (GRAL) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T11:32:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/\",\"name\":\"GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r - GRAIL, Inc. (GRAL) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-20T11:32:07+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; GRAIL, Inc. (GRAL) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r - GRAIL, Inc. (GRAL) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/","og_locale":"tr_TR","og_type":"article","og_title":"GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r - GRAIL, Inc. (GRAL) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T11:32:07+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; GRAIL, Inc. (GRAL) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T11:32:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/","name":"GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r - GRAIL, Inc. (GRAL) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-20T11:32:07+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-grail\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"GRAIL, Inc. (GRAL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; GRAIL, Inc. (GRAL) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":340401,"slug":"how-to-buy-grail","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu GRAIL, Inc. (GRAL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GRAIL, Inc. (GRAL)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-grail\/"},"pt_AA":{"locale":"pt_AA","id":340404,"slug":"how-to-buy-grail","post_title":"Como comprar a\u00e7\u00f5es da GRAIL, Inc. (GRAL) - Investimento em a\u00e7\u00f5es da GRAIL, Inc. (GRAL)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-grail\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=340400"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340400\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=340400"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=340400"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=340400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}